Login / Signup

ZT-01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.

Rawad FarhatJulian AikenNinoschka C D'SouzaDaniel AppaduraiGrayson HullEric SimonsonRichard T LigginsMichael C RiddellOwen Chan
Published in: Diabetes, obesity & metabolism (2022)
We conclude that ZT-01 may be effective in restoring glucagon responses and preventing the onset of hypoglycaemia in patients with T1D.
Keyphrases
  • type diabetes
  • glycemic control
  • insulin resistance
  • cardiovascular disease
  • neuroendocrine tumors
  • metabolic syndrome